Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Accumulated Depreciation & Amortization (2017 - 2022)

Historic Accumulated Depreciation & Amortization for Iterum Therapeutics (ITRM) over the last 6 years, with Q3 2022 value amounting to $274000.0.

  • Iterum Therapeutics' Accumulated Depreciation & Amortization fell 6757.4% to $274000.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $274000.0, marking a year-over-year decrease of 6757.4%. This contributed to the annual value of $286000.0 for FY2021, which is 4435.8% down from last year.
  • Iterum Therapeutics' Accumulated Depreciation & Amortization amounted to $274000.0 in Q3 2022, which was down 6757.4% from $255000.0 recorded in Q2 2022.
  • Iterum Therapeutics' 5-year Accumulated Depreciation & Amortization high stood at $845000.0 for Q3 2021, and its period low was $129000.0 during Q2 2018.
  • Its 5-year average for Accumulated Depreciation & Amortization is $374555.6, with a median of $314500.0 in 2019.
  • Per our database at Business Quant, Iterum Therapeutics' Accumulated Depreciation & Amortization skyrocketed by 20923.08% in 2018 and then plummeted by 6757.4% in 2022.
  • Iterum Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $201000.0 in 2018, then surged by 75.62% to $353000.0 in 2019, then surged by 45.61% to $514000.0 in 2020, then plummeted by 44.36% to $286000.0 in 2021, then decreased by 4.2% to $274000.0 in 2022.
  • Its last three reported values are $274000.0 in Q3 2022, $255000.0 for Q2 2022, and $315000.0 during Q1 2022.